9.27MMarket Cap-101P/E (TTM)
1.1076High1.0300Low356.05KVolume1.1000Open1.0800Pre Close380.10KTurnover4.19%Turnover RatioLossP/E (Static)8.51MShares14.400052wk High5.56P/B9.26MFloat Cap0.280652wk Low--Dividend TTM8.50MShs Float778.0000Historical High--Div YieldTTM7.19%Amplitude0.2800Historical Low1.0670Avg Price1Lot Size
Genprex Stock Forum
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer
Genprex (NASDAQ: GNPX) has secured a worldwide exclusive license from the University of Michigan for patent rights relating to Reqorsa® Gene Therapy in combination with ALK-inhibitors for treating ALK-EML4 positive lung cancer. Preclinical data showed that Reqorsa induced apoptosis in alectinib resistant EML4-ALK positive non-small ...
Genprex Secures Global Patent Rights for Breakthrough Lung Cancer Gene Therapy | GNPX Stock News
today is the day
$Tesla (TSLA.US)$
$Artificial Intelligence (LIST2136.US)$
$NVIDIA (NVDA.US)$
$AT&T (T.US)$
$Phunware (PHUN.US)$
$Tesla (TSLA.US)$
fly to galaxia
$Apple (AAPL.US)$
fly to moon .....
$Tesla (TSLA.US)$
$NVIDIA (NVDA.US)$
No comment yet